Clinical trial / 2011
In smokers, dark chocolate acutely improved flow-mediated dilatation and nitric oxide generation while reducing NOX2 activation and oxidative stress.
In a randomized, single-blind crossover trial, 20 smokers and 20 healthy subjects consumed 40 g of dark chocolate (>85% cocoa) or 40 g of milk chocolate (≤35% cocoa). In smokers, dark chocolate ingestion significantly decreased urinary isoprostanes and sNOX2-dp, while significantly increasing FMD and NOx at 2 hours; no such changes occurred in healthy subjects or after milk chocolate. In smokers, the only independent predictor of changed FMD was the change in sNOX2-dp, and serum epicatechin rose above 0.1 μM in both groups exclusively after dark chocolate.
- Study type
- Randomized, single-blind crossover trial
- Who was studied
- 20 smokers and 20 healthy subjects
- What was measured
- Flow-mediated dilatation, urinary isoprostanes, serum nitrite/nitrate, soluble NOX2-derived peptide, serum epicatechin
THE PAPER
NOX2-mediated arterial dysfunction in smokers: acute effect of dark chocolate.
Loffredo L, Carnevale R, Perri L, Catasca E, Augelletti T, Cangemi R, Albanese F, Piccheri C, Nocella C, Pignatelli P, Violi F. Heart, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.